Lakefront Biotherapeutics | GLPG - مصروفات التشغيل





مصروفات التشغيل تغيير تاريخ
argenx SE USD 1.02B 118M 2026-06
AstraZeneca USD 12.22B 4.04B 2026-06
Biogen USD 2.98B 1.02B 2026-06
Genmab DKK 748M 77M 2026-06
Gilead Sciences USD 3.95B 19.57B 2026-06
GlaxoSmithKline GBP 5.8B 468M 2026-06
GRIFOLS EUR 1.55B 94M 2026-06
Hikma Pharmaceutical USD 1.34B 702M 2025-12
Incyte USD 973.64M 4.65B 2026-06
Merck EUR 4.34B 249M 2026-06
Neurocrine Biosciences USD 739.1M 139.2M 2026-06
Novartis USD 10.2B 912M 2026-06
Roche Holding CHF 18.9B 2.12B 2026-06
Sanofi EUR 9.92B 607M 2026-06
UCB EUR 2.96B 196M 2025-12
Vertex Pharmaceuticals USD 2.07B 217.1M 2026-06